{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260507616597/en/Delcath-Systems-Announces-Presentation-of-New-Data-on-Percutaneous-Hepatic-Perfusion-with-Melphalan-in-Liver-Dominant-Metastatic-Breast-Cancer-at-ESMO-Breast-Cancer-2026", "message": "News view counter 709564 successfully enlarged"}